Market Dynamics Increasing adoption in oncology treatment: The key driver for the growth of the PARP inhibitor market is its increasing adoption in the treatment of various cancers like breast and ovarian cancers. As per the National Cancer Institute, PARP inhibitors have shown promising results in slowing or stopping the growth of cancer cells with BRCA1 or BRCA2 gene mutations. This is...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian